Investigation of the Cardiovascular Effects of Exenatide in Healthy Male Subjects.
Phase of Trial: Phase II
Latest Information Update: 08 Mar 2018
At a glance
- Drugs Exenatide (Primary)
- Indications Non-alcoholic steatohepatitis; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 09 Feb 2012 Results published in the British Journal of Clinical Pharmacology.
- 02 Jun 2010 Planned end date changed from 1 Jan 2010 to 1 Sep 2010 Last checked against ClinicalTrials.gov record.
- 19 Jan 2010 New trial record